Vitexin alters
To further understand the effect of compounds on biofilm regulatory genes, we have 143 determined the relative mRNA expression of dltA, icaAB and agrAC genes using respective 144 primers [ Table S1 ]. Results showed that relative gene expressions of these proteins were 145 significantly reduced where highest fold change was observed in case of vitexin-gentamicin 146 combination treatment [ IcaA was accommodating vitexin in its native binding pocket while in the case of DltA 156 vitexin was occupied in a different position than that of its native ligand [ Fig. 2D ]. In the case 157 of SasG [ Fig. 2D (v, vi) ] protein the vitexin showed a good affinity and bound to the native 158 ligand binding pocket of these proteins. Further, we have energy minimized all vitexin-159 protein complexes to confirm the stability of complexes and it was also observed that all 160 complexes were having a significantly lower potential energies [ Table 1] . 161
Antibiofilm effect of vitexin on S. aureus. Earlier results explain that vitexin reduces S. 162
aureus surface hydrophobicity which have significant role on bacterial cell attachment. In 163
that direction, we have tested effect of vitexin (alone and in combination) on biofilm 164 formation by S. aureus. Results of crystal violet staining showed that vitexin at sub-MIC 165 doses exerted significant biofilm attenuation against the microorganism and maximum 166 activity was measured at 126 µg/ml dose [ Fig. 3A (i) ]. It was also observed that antibiofilm6 was observed in combination with gentamicin. Size of bacterial population in biofilm was 170 determined through total extractable protein from the adhered microbial population. Data 171 showed that vitexin treated samples have less extractable protein contents in comparison to 172 the untreated control [ Fig. 3A (ii) ]. Maximum (69.43%) biofilm attenuation was observed at 173 126 µg/ml dose of vitexin whereas, azithromycin (55 µg/ml) and gentamicin (2.5 µg/ml) have 174 executed synergistic effect on 26 µg/ml of vitexin in attenuating biofilm total. Consistent 175 with the CV staining assay, protein extraction assay also showed a similar pattern of biofilm 176 attenuation [ Fig. 3A (i) and 3A (ii) ]. was also found to be restored [ Fig. 5 (1-6) ]. An additive effect of vitexin (26 µg/ml) and 243 gentamycin (2.5 µg/ml) were also observed and it showed highest healing activity where the 244 central vein, hepatic lobule, liver sinusoid, portal triads are found intact and healthy. The 245 regions of splenic nodules, central artery, trabecular vessels, red pulp, and white pulp were 246 identified in control and all the treatment groups [ Fig. 5 (7-12) ]. Results showed severe 247 structural deformity in the tissue architecture in infection control mouse where it was found 248 to be normalising in vitexin (26 µg/ml)-gentamycin (2.5 µg/ml) treated mouse. In addition to 249 above results, we have determined tissue solidity and roundness through analysis of 250 histological images which depicts that solidity was reduced and roundness was increased with 251 treatment in comparison with untreated control [Fig. 6A ]. This implies that tissue architecture 252 was gradually restored after treatment with vitexin alone and in combination. fluorescence was measured using the FITC-channel and PI stain was measure using PI 523
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